One- or two-week triple therapy for Helicobacter pylori : questions of efficacy and inclusion of a dual therapy treatment arm
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised studyDigestive and Liver Disease, 2004
- Eradication of Helicobacter pylori by 7‐Day Triple‐Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double‐Blind, Randomized StudiesHelicobacter, 2003
- Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.2003
- High eradication rates of Helicobacter pylori with a new sequential treatmentAlimentary Pharmacology & Therapeutics, 2003
- How Can the Current Strategies for Helicobacter pylori Eradication Therapy be Improved?Canadian Journal of Gastroenterology and Hepatology, 2003
- Risk factors for failure of Helicobacter pylori therapy — results of an individual data analysis of 2751 patientsAlimentary Pharmacology & Therapeutics, 2002
- Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in ItalyAlimentary Pharmacology & Therapeutics, 2002
- cagA Status and Eradication Treatment Outcome of Anti- Helicobacter pylori Triple Therapies in Patients with Nonulcer DyspepsiaJournal of Clinical Microbiology, 2001
- A meta‐analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 2000
- Furazolidone combination therapies for Helicobacter pylori infection in the United StatesAlimentary Pharmacology & Therapeutics, 2000